The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
International gathering at UH examines top computer code

Not only can FLUKA be used to determine the therapeutic dose delivered to the tissue of interest in the body, but it also can be used to assess the collateral exposure to the surrounding tissue, so that treatment plans can be optimized," Pinsky said.

One of the greatest challenges facing researchers is to protect astronauts from the radiation environment in space.

"At the surface of the Earth, we are protected from the most harmful sources of cosmic radiation by the effects of the Earth's magnetic field and the thickness of our atmosphere," Pinsky said. "In space beyond the Earth's atmosphere, the radiation environment is significantly more intense."

As human space exploration ventures farther from Earth for longer periods, stronger and lighter shielding materials for spacecraft must be developed to protect astronauts from the harmful effects of this radiation. To give shielding recommendations, certain calculations must be employed. These shielding calculations also can be used for nuclear reactors and accelerators, and FLUKA is the most widely used and trusted computer code to do this.

Along with UH and NASA, the course is being sponsored by the European Organization for Nuclear Research (CERN), which is the world's largest particle physics lab where physicists go to explore the make up of matter and forces holding it together, and the National Institute of Nuclear Physics (INFN), the Italian funding agency for nuclear physics.

Physicist Johann Ranft at the University of Leipzig in Germany originally developed FLUKA in the 1960s while he was working with CERN. By the late 1980s, the code had evolved through two generations, and Ranft turned over the continuing development and modernization of the code to a group of physicists at the INFN, who work with Alfredo Ferrari, who also is a senior physicist at CERN. The present version of FLUKA is the product of this team of authors.

Following the course hel
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
20-Dec-2004


Page: 1 2 3

Related medicine news :

1. International breast cancer prevention study launches in the United States and Canada
2. National Academies advisory: May 2 Symposium on International Science Policy
3. Awards & fellowships at the International & American Association for Dental Research General Session
4. Lectures, keynoters, symposia highlight International Dental Research meeting
5. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
6. International gathering of experts to share retinoblastoma breakthroughs
7. International trial of two microbicides begins
8. International trial finds benefits of breast MRI in women at high risk
9. International study provides culture-by-culture clues to family violence and abuse
10. St. Jude scientist wins International Society of Experimental Hematology award
11. International MRC trial finds a routine treatment for head injury may do more harm than good

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: International gathering examines top computer code

(Date:11/25/2009)...zlesmile,llc www.dazzlesmile.com andOptimalHealthS...67-pagefederallawsuitagainstEpicAdvertisingAKAAzoo...esLimited,andAtLastFulfillment.The13-countComplain...ictofUtah,allegesmassivenationalconsumerfraud,coun...oducts,violationsoftheRacketeeringInfluencedandCor...
(Date:11/25/2009)...roveOverallOutcomesforLungCancer ,, WASHINGTO...rAlliance-California(LCA-CA)issuedits2ndAnnual Rep...ntofprogressbeingmadeagainstthislethaldiseaseinthe...ance(LCA),theonlynationalorganizationdedicatedexcl...ithoratriskforlungcancer. ,, (Photo: http://www...
(Date:11/25/2009)...matology (ASH) is pleased to recognize the followi...bstracts in the categories of undergraduate studen...ysician, and post-doctoral,fellow. Merit Award wi...g,travel reimbursement. , The 2009 Merit Award ...imberly Fan , Donor Dendritic Cells Home to Lymph...
(Date:11/25/2009)... , An innovative treatment for HIV patients dev...ers has passed its first clinical trial with flyin...stomized for each individual patient, and was deve...e of the MUHC in collaboration with Dr. R. Skaly f...ade for the individual patient an "haute couture"...
(Date:11/25/2009)...atients with liver lesions, researchers find , ...ding the drug cetuximab to neoadjuvant chemotherap...ul surgery in colorectal cancer patients with inop...ests. , , Tumors spread to other parts of the ... cancer. Most commonly, the cancer spreads to the ...
Breaking Medicine News(10 mins):Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:ASH announces 2009 Merit Award winners 2Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Cetuximab Helps Treat Colorectal Cancer 2
(Date:11/25/2009)....25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABA...arebloodanalysissystems,announcedtodaythatClintSev...atthe21stAnnualPiperJaffrayHealthCareConferenceonW...illbeheldattheNewYorkPalaceHotelinNewYorkCity. ,...andmarketsportablebloodanalysissystemsforuseinanyv...
(Date:11/25/2009)...wswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),am...inimallydisruptivesurgicaltreatmentsforthespine,an...November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfere...mentfortheCompany,sproductsandwillincludecommentsf...ion.Thedial-innumbersare1-877-407-4018fordomesticc...
(Date:11/25/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...nasalDrugDelivery-USMarketTrends&Analysis htt...Delivery---US-Market-Trends--Analysis.html ,, ...ansionoftherapeuticapplicationsfromthedeliveryofco...emictherapeuticdrugs.Thefutureofthetechnologyhinge...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Sentry Data Systems Announces Claims Guardian 28TM 29 50150 1Sentry Data Systems Announces Claims Guardian 28TM 29 50150 2Sentry Data Systems Announces Claims Guardian 28TM 29 50150 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 1Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 4Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 5Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 1Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 2Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 3
Other News:
...seeking people with arthritis to help them better ...fects their symptoms. The study will investigate t...processes of those with arthritis.......Research p...mmon in people with arthritis, and arthritis patie...
...form many separations of molecules before they beg...ive compound or sub-compound into a drug.......Des...st chemically benign separation processes has not ...inia Tech researchers with support from Procter & ...
...-income single mothers have a very high prevalence...n Peden, ARNP, BC, DSN at the University of Kentuc... women with children between the ages of 2 and 6 w...ipants' survey results showed that more than 75% s...
...ected to grow faster than the population in the ne...creased demand in 89 of the state's 102 counties, ...ois State Water Survey.... ..."These studies proje...her states in the Midwest, information that is cri...
health news:Countywide forecasts of water use available for Illinois, Midwest 2health news:Countywide forecasts of water use available for Illinois, Midwest 3
...ng stents are effective in keeping open diseased h...s who need to have non-cardiac surgery a short tim...ntation at the Society for Cardiovascular Angiogra...at Jefferson Medical College indicates that for th...
...e treatment of heart attack, the 90-minute goal fo... coronary artery to restore normal blood flow is s..., accreditation standards, and pay-for-performance...itical" Two experts will debate that question at t...
...ent with double-dose anticlotting medication just ...ts the combined risk of heart attack and cardiac d... 30th Annual Scientific Sessions of the Society fo...AI), May 912, 2007, in Orlando, FL. ... Researcher...
WASHINGTON, May 11 Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two, if their current treatment combines the lipid
health news:Bare-metal stents are better for some heart patients 2health news:Debate focuses on door-to-balloon time in heart attack treatment 2health news:High-dose anticlotting drug cuts heart attack, death risk in half 2health news:One pill may be better than two for treating patients with high blood pressure 2health news:One pill may be better than two for treating patients with high blood pressure 3